Table 3.
Laboratory findings of patients infected with COVID‐19 on admission to hospital
| All patients (n = 135) | Mild cases (n = 95) | Severe cases (n = 40) | P value | |
|---|---|---|---|---|
| White cell count, ×109/L | 5.4 (4.1‐7.8) | 5.5 (4.0‐8.0) | 5.2 (4.9‐6.9) | .6750 |
| <3.5 | 28 | 24 (25%) | 4 (10%) | … |
| 3.5‐9.5 | 98 | 65 (68%) | 33 (82.5%) | .0043 |
| >9.5 | 9 | 6 (7%) | 3 (7.5%) | … |
| Neutrophil count, ×109/L | 3.5 (2.6‐4.4) | 3.6 (3.0‐3.9) | 4.1 (3.1‐5.7) | .0015 |
| Lymphocyte count, ×109/L | 1.1 (0.7‐1.5) | 1.2 (0.8‐1.6) | 0.8 (0.6‐1.0) | <.0001 |
| <1.1 | 68 | 36 (38%) | 32 (80%) | .2938 |
| ≥1.1 | 67 | 59 (62%) | 8 (20%) | … |
| Hemoglobin, g/L | 133 (122‐147) | 134 (124‐147) | 130 (120‐143) | .1001 |
| Platelet count, ×109/L | 158 (131‐230) | 170 (136‐234) | 147 (118‐213) | .0306 |
| <125 | 23 (17%) | 11 (11.6%) | 12 (30%) | .8198 |
| ≥125 | 112 (83%) | 84 (88.4%) | 28 (70%) | .4920 |
| Prothrombin time, s | 10.9 (10.5‐11.4) | 10.8 (10.4‐11.3) | 11.3 (10.7‐11.8) | .0114 |
| Activated partial thromboplastin time, s | 26.9 (24.7‐29) | 26.6 (24.5‐28.8) | 29.7 (226.2‐39.4) | .0003 |
| d‐dimer, mg/L | 0.4 (0.2‐0.6) | 0.3 (0.2‐0.5) | 0.6 (0.4‐1.1) | <.0001 |
| Albumin, g/L | 40.5 (37‐43.4) | 49.9 (37.4‐43.6) | 36 (33‐38.5) | <.0001 |
| Alanine aminotransferase, U/L | 26 (12.9‐33.15) | 21.7 (14.8‐36.9) | 26.6 (14.5‐33.3) | .7324 |
| Aspartate aminotransferase, U/L | 33.4 (27.8‐43.7) | 22.4 (16.9‐30.5) | 33.6 (25.7‐44.2) | <.0001 |
| ≤40 | 105 | 80 (84%) | 25 (62.5%) | .0005 |
| >40 | 30 | 15 (16%) | 15 (37.5%) | .8460 |
| Total bilirubin, μmol/L | 8.6 (5.9‐13.7) | 8.6 (5.6‐14) | 9.8 (7.8‐15.6) | .0716 |
| Potassium, mmol/L | 4 (3.55‐4.41) | 4 (3.7‐4.5) | 3.8 (3.5‐4.3) | .0550 |
| Sodium, mmol/L | 139 (137‐141) | 139 (137.2‐141) | 136.5 (133‐138) | <.0001 |
| Creatine, μmol/L | 66 (57.8‐74.5) | 66 (55‐79) | 63.5 (51.5‐74.3) | .2306 |
| ≤97 | 129 (95.6%) | 92 (97%) | 37 (92.5%) | .0835 |
| >97 | 6 (4.4%) | 3 (3%) | 3 (7.5%) | … |
| Creatine kinase, U/L | 82.2 (56.3‐146.3) | 57 (36.5‐86.5) | 82 (56.3‐146.2) | .0016 |
| ≤200 | 125 (92.6%) | 92 (97%) | 33 (82.5%) | .0307 |
| >200 | 10 (7.4%) | 3 (3%) | 7 (17.5%) | … |
| Lactate dehydrogenase, U/L | 320.5 (248.5‐385.3) | 212 (179.5‐259) | 309 (253.8‐408.3) | <.0001 |
| ≤250 | 77 (57%) | 67 (71%) | 10 (25%) | … |
| >250 | 58 (43%) | 28 (29%) | 30 (75%) | .0055 |
| C‐reactive protein, mg/L | 10.5 (2.7‐51.2) | 7.7 (1.9‐31.1) | 91 (52.7‐136.3) | <.0001 |
| Procalcitonin, ng/mL | 0.11 (0.08‐0.16) | 0.04 (0.03‐0.06) | 0.11 (0.08‐0.16) | <.0001 |
| <0.1 | 110 (81.5%) | 89 (94%) | 21 (52.5%) | <.0001 |
| ≥0.1‐0.25 | 21 (15.6%) | 6 (6%) | 15 (37.5%) | .1708 |
| ≥0.25‐0.5 | 3 (2.2%) | 0 | 3 (7.5%) | … |
| ≥0.5 | 1 (0.7%) | 0 | 1 (2.5%) | … |
| Bilateral involvement of chest radiographs | 135 (100%) | 95 (100%) | 40 (100%) | … |
Abbreviation: COVID‐19, coronavirus disease.